Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Remarks:
intraperitoneal
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1973
Report date:
1973

Materials and methods

Principles of method if other than guideline:
no information available
GLP compliance:
no
Remarks:
Study conducted prior to implementation of GLP

Test material

Constituent 1
Chemical structure
Reference substance name:
3-hydroxy-2-methylquinoline-4-carboxylic acid
EC Number:
204-198-1
EC Name:
3-hydroxy-2-methylquinoline-4-carboxylic acid
Cas Number:
117-57-7
Molecular formula:
C11H9NO3
IUPAC Name:
3-hydroxy-2-methylquinoline-4-carboxylic acid

Test animals

Species:
mouse
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
CMC (carboxymethyl cellulose)
Details on exposure:
VEHICLE
- Concentration in vehicle: 2-30%
Control animals:
not specified

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
ca. 470 mg/kg bw
Based on:
act. ingr.
Clinical signs:
slight apathy, partly dyspnoea, at high doses twitching and spring cramps
Gross pathology:
intraabdominal substance precipitation

Applicant's summary and conclusion

Conclusions:
The intraperitoneal LD50 of 3-hydroxy-2-methylquinoline-4-carboxylic acid in mice was ca. 470 mg/kg bw.
Executive summary:

In an acute toxicity study, mice were given a single dose of 3-hydroxy-2-methylquinoline-4-carboxylic acid in aqueous suspension with carboxymethyl cellulose by intraperitoneal administration and were observed for 7 days.

During the observation period, clinical signs were slight apathy, partly dyspnoea, at high doses twitching and spring cramps. During gross pathology, intraabdominal substance precipitation was observed.

Intraperitonal LD50 (mice) ca. 470 mg/kg bw